Acurx Pharmaceuticals, Inc. (ACXP)
NASDAQ: ACXP · Real-Time Price · USD
1.955
+0.605 (44.81%)
At close: Mar 9, 2026, 4:00 PM EDT
1.930
-0.025 (-1.28%)
After-hours: Mar 9, 2026, 4:56 PM EDT
Acurx Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 5 | 14 | 53 | 46 | 44 | - | |
| Market Cap Growth | -62.56% | -73.92% | 14.29% | 4.51% | - | - | |
| Enterprise Value | -2 | 8 | 46 | 36 | 30 | - | |
| Last Close Price | 1.35 | 16.28 | 76.60 | 79.60 | 86.43 | - | |
| PB Ratio | 0.67 | 22.35 | 11.30 | 6.31 | 3.56 | - | |
| P/TBV Ratio | 0.95 | 22.35 | 11.30 | 6.31 | 3.56 | - | |
| Debt / Equity Ratio | - | - | - | - | - | 0.03 | |
| Net Debt / Equity Ratio | -1.62 | -6.03 | -1.60 | -1.25 | -1.04 | -1.15 | |
| Quick Ratio | 2.41 | 1.16 | 2.50 | 4.42 | 15.36 | 6.72 | |
| Current Ratio | 2.47 | 1.19 | 2.53 | 4.55 | 15.71 | 6.82 | |
| Return on Equity (ROE) | -291.06% | -534.03% | -243.33% | -122.61% | -168.71% | -261.26% | |
| Return on Assets (ROA) | -95.64% | -152.41% | -106.65% | -66.79% | -97.21% | -99.91% | |
| Return on Capital Employed (ROCE) | -254.30% | -2292.70% | -312.40% | -165.30% | -103.30% | -167.20% | |
| Earnings Yield | -266.72% | -102.56% | -27.64% | -26.21% | -28.88% | - | |
| Buyback Yield / Dilution | -51.82% | -27.56% | -17.15% | -26.72% | -37.88% | -30.29% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.